Predicting the treatment effect of sorafenib using serum angiogenesis markers in patients with hepatocellular carcinoma
Koji Miyahara(Okayama University), Kazuhide Yamamoto(Kurume University Medical Center), Kenji Kuwaki(Massachusetts General Hospital), Hidenori Shiraha(Kawasaki Medical School), Hideki Onishi(Okayama University), Takeshi Tomoda(Okayama University), Junichi Toshimori(Okayama University), Akinobu Takaki(Okayama University), Yasuhiro Miyake(High Energy Accelerator Research Organization), Fusao Ikeda(Okayama University), Sayo Kobayashi(Okayama University), Hiroaki Hagihara(Okayama University), Shinichiro Nakamura(Himeji Red Cross Hospital), Kazuhiro Nouso(Okayama Prefecture)
Cited by 90
Related Papers
Heart transplantation in baboons using α1,3-galactosyltransferase gene-knockout pigs as donors: initial experience
|Nature Medicine|2004|697
Genome-wide Association Study Identifies TNFSF15 and POU2AF1 as Susceptibility Loci for Primary Biliary Cirrhosis in the Japanese Population
|The American Journal of Human Genetics|2012|272
A new approach for measuring the muon anomalous magnetic moment and electric dipole moment
|Progress of Theoretical and Experimental Physics|2019|239